ALT
Price
$3.87
Change
+$0.37 (+10.57%)
Updated
Jun 30 closing price
Capitalization
313.88M
37 days until earnings call
KROS
Price
$13.35
Change
-$0.14 (-1.04%)
Updated
Jun 30 closing price
Capitalization
542.22M
30 days until earnings call
Interact to see
Advertisement

ALT vs KROS

Header iconALT vs KROS Comparison
Open Charts ALT vs KROSBanner chart's image
Altimmune
Price$3.87
Change+$0.37 (+10.57%)
Volume$19.1M
Capitalization313.88M
Keros Therapeutics
Price$13.35
Change-$0.14 (-1.04%)
Volume$392.92K
Capitalization542.22M
ALT vs KROS Comparison Chart in %
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. KROS commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a StrongBuy and KROS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (ALT: $3.87 vs. KROS: $13.35)
Brand notoriety: ALT and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 335% vs. KROS: 57%
Market capitalization -- ALT: $313.88M vs. KROS: $542.22M
ALT [@Biotechnology] is valued at $313.88M. KROS’s [@Biotechnology] market capitalization is $542.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileKROS’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • KROS’s FA Score: 1 green, 4 red.
According to our system of comparison, KROS is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 5 TA indicator(s) are bullish while KROS’s TA Score has 3 bullish TA indicator(s).

  • ALT’s TA Score: 5 bullish, 4 bearish.
  • KROS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALT is a better buy in the short-term than KROS.

Price Growth

ALT (@Biotechnology) experienced а -44.64% price change this week, while KROS (@Biotechnology) price change was -2.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.71%. For the same industry, the average monthly price growth was +31.92%, and the average quarterly price growth was +6.10%.

Reported Earning Dates

ALT is expected to report earnings on Aug 07, 2025.

KROS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+3.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($542M) has a higher market cap than ALT($314M). KROS YTD gains are higher at: -15.666 vs. ALT (-46.325). KROS has higher annual earnings (EBITDA): 14.8M vs. ALT (-90.75M). KROS has more cash in the bank: 721M vs. ALT (150M). ALT has less debt than KROS: ALT (1.59M) vs KROS (18.4M). KROS has higher revenues than ALT: KROS (215M) vs ALT (20K).
ALTKROSALT / KROS
Capitalization314M542M58%
EBITDA-90.75M14.8M-613%
Gain YTD-46.325-15.666296%
P/E RatioN/AN/A-
Revenue20K215M0%
Total Cash150M721M21%
Total Debt1.59M18.4M9%
FUNDAMENTALS RATINGS
ALT: Fundamental Ratings
ALT
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALTKROS
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 29 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USGRX24.62N/A
N/A
Victory Growth & Income
BFTIX63.98N/A
N/A
Baron Fifth Avenue Growth Instl
FFIMX21.67N/A
N/A
Fidelity Advisor Asset Manager 50% I
PVCIX12.35N/A
N/A
Palm Valley Capital Institutional
CFMVX23.92N/A
N/A
Commerce MidCap Value

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INZY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
-1.04%
INZY - KROS
43%
Loosely correlated
+0.25%
AXON - KROS
43%
Loosely correlated
+1.14%
RAPT - KROS
39%
Loosely correlated
-5.10%
DNLI - KROS
39%
Loosely correlated
-0.78%
VERV - KROS
39%
Loosely correlated
-0.62%
More